ArticleFrontiers in public health2025
How to measure the effectiveness of recovery community centers: insights gained from a nationwide survey of directors of RCCs.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Objective: Recovery community centers (RCCs) are a rapidly growing source of support for many Americans seeking or in recovery from substance use disorder. Research that examines the effectiveness of RCCs is critically needed. Determining how the "effectiveness" of RCCs ought to be measured, however, is challenging, because RCCs seek to confer benefits on multiple levels and because recovery is a multi-faceted construct. RCC directors are uniquely suited to provide insight into what outcome measures may be viable to use to capture the impact of RCCs on their participants. Methods: As part of a nationwide survey of RCCs directors ( Results: All measures had considerable buy-in from RCC directors: 87% or more of RCC directors said RCC participants would show progress on each measure, and 72% or more said that each measure would be useful to demonstrate the impact of their RCC. Most frequently, RCC directors endorsed as useful the list of ways in which RCCs confer benefit, the list of life goals, and the BARC-10 (≥95% of RCC directors each). RCC directors were split on which measure would be the best measure, with no single measure exceeding 26% of RCC directors rating it as the best of the seven presented scales. Conclusion: Several existing scales resonate with RCC directors, yet little consensus regarding a single primary outcome variable exists. Close collaboration with RCCs is needed to ensure that research on the effectiveness of RCCs is congruent with how RCCs function and seek to confer benefit.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.